| Cat. No. |
Product Name |
Information |
| PC-72806 |
DS0464
SARS-CoV-2 nsp14 inhibitor
|
DS0464 is a selective, bisubstrate competitive inhibitor SARS-CoV-2 nonstructural protein 14 (nsp14) with IC50 of 1.1 uM, also selective against 28 out of 33 RNA, DNA, and protein MTases. |
| PC-72805 |
N-0385
TMPRSS2 inhibitor
|
N-0385 (N 0385, Ms-Gln-Phe-Arg-kbt) is a potent, selective inhibitor of TMPRSS2 with IC50 of 1.9 nM |
| PC-72800 |
SSYA 10-001
SARS-CoV-2 Nsp13 inhibitor
|
SSYA 10-001 (DSHS00884, SSYA10-001) is a small molecule inhibitor of SARS-CoV-2 Nsp13 helicase with IC50 of 3.5 uM. |
| PC-72752 |
PF-00835231
3CLpro inhibitor
|
PF-00835231 (PF00835231) is a potent inhibitor of pan-coronavirus family 3CL pro (IC50=0.27 nM, SARS CoV-2), with selectivity over human host protease targets |
| PC-72751 |
PF-07304814
3CL pro inhibitor
|
PF-07304814 (PF 07304814, Lufotrelvir) is a phosphate prodrug of PF-00835231, which is a potent, selective inhibitor of pan-coronavirus family 3CL pro. |
| PC-72735 |
MCULE-5948770040
SARS-CoV-2 Mpro inhibitor
|
MCULE-5948770040 is a competitive noncovalent inhibitor of SARS-CoV-2 main protease (Mpro) with IC50 of 0.68 uM. |
| PC-72607 |
PF-07321332
SARS-CoV-2 Mpro inhibitor
|
PF-07321332 (Nirmatrelvir, Paxlovid) is the first, orally bioavailable SARS-CoV-2 main protease (M pro) inhibitor with biochemical Ki of 3.11 nM. |
| PC-72198 |
CCF0058981
3CLpro inhibitor
|
CCF0058981 (CCF981) is a potent, selective, noncovalent inhibitor of the SARS-CoV-1/SARS-CoV-2 3CL protease (3CLpro) with IC50 of 19 and 68 nM, respectively. |
| PC-72126 |
Cyanorona-20
SARS-CoV-2 inhibitor
|
Cyanorona-20 is a potent and specific SARS-CoV-2 inhibitor with very high selectivity (209- and 45-fold more potent than favipiravir and remdesivir, respectively), effectively binds to and inhibits the SARS-CoV-2 RdRp. |
| PC-72069 |
EIDD-1931
SARS-CoV-2 inhibitor
|
EIDD-1931 (Beta-d-N4-hydroxycytidine, β-d-N4-hydroxycytidine, NHC) is an active metabolite of EIDD-2801 with broad-spectrum antiviral inhibitor of SARS-CoV-2. |
| PC-38282 |
P2165
Spike RBD-ACE2 inhibitor
|
P2165 (P-2165) is a anticoronaviruse chemical probe that inhibit SARS-CoV-2 Spike binding to human ACE2 receptor. |
| PC-38281 |
P2119
Spike RBD-ACE2 inhibitor
|
P2119 (P-2119) is an anticoronaviruse chemical probe that inhibit SARS-CoV-2 Spike binding to human ACE2 receptor. |
